These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24383119)
41. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses. Udell JA; Opotowsky AR; Khairy P; Silversides CK; Gladstone DJ; O'Gara PT; Landzberg MJ Can J Cardiol; 2014 Oct; 30(10):1216-24. PubMed ID: 25154803 [TBL] [Abstract][Full Text] [Related]
42. Ischemic Stroke Mandates Cross-Disciplinary Collaboration. Fisher M; Hill JA Circulation; 2018 Jan; 137(2):103-105. PubMed ID: 29311344 [No Abstract] [Full Text] [Related]
43. Percutaneous Closure Versus Medical Treatment in Stroke Patients With Patent Foramen Ovale: A Systematic Review and Meta-analysis. De Rosa S; Sievert H; Sabatino J; Polimeni A; Sorrentino S; Indolfi C Ann Intern Med; 2018 Mar; 168(5):343-350. PubMed ID: 29310133 [TBL] [Abstract][Full Text] [Related]
44. Patent foramen ovale and stroke. Miranda B; Fonseca AC; Ferro JM J Neurol; 2018 Aug; 265(8):1943-1949. PubMed ID: 29680895 [TBL] [Abstract][Full Text] [Related]
45. Percutaneous closure of patent foramen ovale: safe and effective but underutilized. Nietlispach F; Meier B Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):121-3. PubMed ID: 25556896 [TBL] [Abstract][Full Text] [Related]
46. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Messé SR; Kasner SE Circulation; 2008 Nov; 118(19):1999-2004. PubMed ID: 18981314 [No Abstract] [Full Text] [Related]
47. Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials. Riaz H; Khan MS; Schenone AL; Waheed AA; Khan AR; Krasuski RA Am Heart J; 2018 May; 199():44-50. PubMed ID: 29754665 [TBL] [Abstract][Full Text] [Related]
48. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale. Patti G; Pelliccia F; Gaudio C; Greco C Am J Cardiol; 2015 Mar; 115(6):837-43. PubMed ID: 25620037 [TBL] [Abstract][Full Text] [Related]
49. Stroke prevention by percutaneous closure of patent foramen ovale: a meta-analytic review. Nagaraja V; Eslick GD Int J Cardiol; 2014 Mar; 172(2):524-6. PubMed ID: 24485622 [No Abstract] [Full Text] [Related]
50. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618 [TBL] [Abstract][Full Text] [Related]
51. Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials. Niu X; Ou-Yang G; Yan PF; Huang SL; Zhang ZT; Zhang ZH J Neurol; 2018 Jun; 265(6):1259-1268. PubMed ID: 29383514 [TBL] [Abstract][Full Text] [Related]
52. Patent Foramen Ovale Closure in the Setting of Cryptogenic Stroke: A Meta-Analysis of Five Randomized Trials. Garg L; Haleem A; Varade S; Sivakumar K; Shah M; Patel B; Agarwal M; Agrawal S; Leary M; Kluck B J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2484-2493. PubMed ID: 29805084 [TBL] [Abstract][Full Text] [Related]
53. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ; J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622 [TBL] [Abstract][Full Text] [Related]
54. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ; Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754 [TBL] [Abstract][Full Text] [Related]
55. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Ntaios G; Papavasileiou V; Makaritsis K; Michel P Int J Cardiol; 2013 Oct; 169(2):101-5. PubMed ID: 24041984 [TBL] [Abstract][Full Text] [Related]
56. Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies. Odunukan OW; Price MJ Interv Cardiol Clin; 2017 Oct; 6(4):525-538. PubMed ID: 28886843 [TBL] [Abstract][Full Text] [Related]